Lower urinary tract symptoms (LUTS) and erectile dysfunction (ED) are age-related conditions that may have a profound impact on the quality of life. The relationship between LUTS and ED is not completely understood. In this study, we assessed this relationship in men over 45 years of age during a prostate cancer screening program. LUTS and ED were evaluated in 1267 men aged 45-75 years (mean 58.278.2 years). Patients completed the International Prostate Symptom Score (IPSS) and the International Index of Erectile Function-5 (IIEF-5). The association between LUTS and ED was analyzed and the influence of age in the results was tested. We also evaluated the influence of the intensity of LUTS in the ED severity. A total of 514 (40.6%) patients were considered symptomatic of LUTS (24.8% with mild, 11.8% with moderate and 4% with severe LUTS). ED was present in 758 (59.9%) men and was considered mild in 25.0%, moderate in 18.3% and severe in 16.7%. The IIEF-5 score had a negative correlation with both the IPSS score (r ¼ À0.33, Po0.001) and age (r ¼ À0.31 and Po0.001). Age was positively associated with the IPSS score (r ¼ 0.14 and Po0.001). A significant correlation was observed between LUTS and ED, with 57.6% of the men with LUTS presenting ED as opposed to 29.7% of the asymptomatic population (odds ratio ¼ 3.32; 95% CI ¼ 2.57-4.29, Po0.001). Age-adjusted univariate analysis revealed a significant and independent influence of LUTS on the incidence of ED (odds ratio ¼ 2.72; 95% CI ¼ 2.08-3.57, Po0.001). IIEF scores varied significantly according to the severity of the urinary symptoms. Our findings in a prostate cancer screening population confirm that LUTS is an age-independent predictor of ED. Furthermore, they demonstrate that not only the presence of LUTS increases the likelihood of developing ED, but the severity of LUTS is associated with the intensity of ED.
Introduction
Lower urinary tract symptoms (LUTS) are an aggregate of voiding symptoms, including urinary frequency, urgency, nocturia and slow stream, and are frequently caused by benign prostatic hyperplasia (BPH). LUTS and erectile dysfunction (ED) are common problems among aging populations and may have a profound impact on the quality of life. 1 The presence of histological BPH at autopsy increases from 8% in men aged 31-40 years to 90% in those aged 81-90 years. 2, 3 Male sexual dysfunction is also an age-related condition with worldwide estimates of ED prevalence of 2% in men younger than 40 years and 86% in those aged 80 years or more. 3, 4 Conditions such as diabetes, cigarette smoking and cardiovascular diseases are clearly associated with ED. 3 The relationship between LUTS and ED, however, is not completely understood. Recent studies have consistently demonstrated evidence of an association between LUTS/BPH and sexual dysfunction in aging men that is independent of the effects of age, other comorbidities and lifestyle factors.
In this study, we assessed the association between LUTS and ED in men over 45 years of age during a prostate cancer screening program.
Materials and methods
After Institutional Review Board approval, men aged 45-75 years who were participating in a prostate cancer screening program in the area of Joinville (southern Brazil) were invited to participate in this study and completed the International Prostate Symptom Score (IPSS) 4 and the International Index of Erectile Function-5 (IIEF-5). 5 Patients were excluded from the study if they had a history of previous treatment for prostate diseases and/or LUTS within 6 months before the evaluation. The association between LUTS and ED was evaluated and the influence of age on the results was tested. Patients were classified as having ED if the total score of the IIEF-5 was less than 22. ED was considered mild if the IIEF-5 score was between 17 and 21, moderate between 11 and 16 and severe if less than 10. LUTS was classified according to the IPSS, and was considered mild if the score was 0-7, moderate between 8 and 18 and severe if more than 19.
Statistical analysis
Numerical data were reported as the mean7s.d. and range. Categorical variables were reported as number and percentages. Pearson's correlation analysis was used to describe associations between the predictor variables of the regression models. Multiple logistic regression analyses adjusted for age further examined the association between ED and LUTS. The dependent variable was the ED rate, defined by the IIEF-5 cutoff score of 22 or less, and the severity of LUTS and age were considered dependent variables. To evaluate the influence of the intensity of LUTS and age on ED severity, the analysis of covariance was performed, with a Bonferroni posttest. Data were processed using the SPSS 11.0 for Windows statistical software and Po0.05 was considered significant.
Results
A total of 1267 men completed the questionnaires and were included in the study. The mean age of the patients was 58.278.2 years (range 45-75 years). Of the patients, 456 patients aged between 45 and 55 years (mean 50.172.6), 539 between 56 and 65 years (mean 59.772.9) and 254 between 66 and 75 years (mean 6973.2).
In this sample, the overall prevalence of LUTS was 40.6%, with 24.8% presenting mild symptoms, 11.8% moderate and 4% severe LUTS. ED affected 59.9% of the patients and was considered mild in 25.0%, moderate in 18.3% and severe in 16.7%.
The IIEF-5 score showed a significant negative correlation with both the IPSS score (r ¼ À0.33, Po0.001) and age (r ¼ À0.31 and Po0.001) (Figure 1 ). Age was positively associated with the IPSS score (r ¼ 0.14 and Po0.001).
A significant correlation was observed between LUTS and ED, with 57.6% of the men with LUTS presenting ED as opposed to 29.7% of the asymptomatic population (odds ratio ¼ 3.32; 95% CI ¼ 2.57-4.29, Po0.001).
Multiple logistic regression analysis examined potential influences of the predictor variables age and LUTS on the occurrence of ED. Age-adjusted univariate analysis revealed a significant and independent influence of LUTS on the incidence of ED (odds ratio ¼ 2.72; 95% CI ¼ 2.08-3.57, Po0.001).
The mean IIEF scores varied significantly according to the severity of the urinary symptoms, with the more symptomatic patients presenting increased ED (lower IIEF-5 score) (Po0.001) (Figure 2 ). After ageadjusted correction, this effect remained, despite of reduction in its magnitude (Table 1) .
Discussion
Sexuality is an essential aspect of quality of life and the advent of effective oral treatments for ED has increased the longevity of sexual life for elders. ED is a multifactorial condition, with well-known risk factors as aging, comorbid conditions, certain medications, obesity and life-style behaviors, for example, alcohol and tobacco use.
The relationship between ED and LUTS is not well known. Although the pathophysiological link Prostate cancer screening E Reggio et al between LUTS and ED is not understood, there is compelling epidemiological evidence suggesting a significant association between LUTS and sexual dysfunction in aging men worldwide, independently of age and other comorbidities.
In the present study, we assessed the relationship between LUTS and ED in a cohort of Brazilian men. The study population was enrolled from a prostate cancer screening program after voluntarily seeking the urologic center. Therefore, our sample was not completely community based, which may have introduced some bias, since patients seeking a prostate cancer screening program may be more symptomatic than the age-matched population. Despite this, we believe that the patients enrolled in the study are a representative group of men between 45 and 75 years of age, since we excluded those who had been treated or were receiving treatment for LUTS. Moreover, the potential effects of a selection bias in a population-based trial cannot be completely eliminated, as discussed by Rosen et al. 6 It is possible that people with a lesser degree of LUTS or sexual dysfunction are less interested in taking part in a study based on mailed self-reported questionnaires.
Sexual and voiding functions were evaluated using standard validated methods to collect data that were also used in most populational studies evaluating LUTS and ED. 7, 8 The overall prevalence of LUTS was 40.6%, while ED affected 59.9% of the patients. In two large-scale population-based studies, the prevalence of ED was 49-52%. 1, 6 Among patients seeking help for voiding problems, as many as 69% may present ED. Our numbers are somewhat in between these prevalences, which may be explained by the fact that patients seeking a prostate cancer screening program may have a tendency to have more severe LUTS than the average population.
Our findings in a prostate cancer screening population confirm that LUTS is an age-independent predictor of ED. Furthermore, they demonstrate that not only the presence of LUTS increases the likelihood of developing ED, but the severity of LUTS is associated with the intensity of ED. These data are in accordance with other studies. Boyle et al. 9 reported a large-scale multinational investigation of LUTS and ED, which demonstrated an unequivocal association between LUTS and ED that is independent of age or other comorbidities. Data from an epidemioplogic study of Chung et al., 10 using self-administered questionnaires, suggest that sexual function is inversely associated with LUTS severity and that this association is only partially attributable to the confounding effects of age. Additionally, McVary 11 used the Hill's causality method to show a strong association between LUTS and ED with regard to internal consistency and dose-response effects.
The results of longitudinal population-based studies also indicate a significant association between LUTS and ED. In a study involving 428 men without ED at baseline, the adjusted relative risk of developing ED was 3.67 for those with self-reported BPH after a mean follow-up of 2 years. 12 Paick et al. 13 have also found a longitudinal association between LUTS and ED in men with enlarged prostate. Interestingly, prostate specific antigen (PSA) and ED were not associated in this study, which emphasizes the need for a better understanding of the mechanisms underlying BPH related sexual dysfunction.
The precise association and possible relationships between both states are not clear. There are some hypotheses to explain this link. Reduction of nitric oxide synthase and nitric oxide, largely discussed after the studies with phosphodiesterase type-5 (PDE-5) inhibitors for ED treatment, could increase the smooth muscle cell contractile forces at the bladder neck and prostatic urethra, causing LUTS. 14, 15 Following this theory, PDE-5 inhibitors could be used for LUTS treatment. The autonomic hyperactivity theory is based on the increase of sympathetic tone, caused by aging, physical inactivity and many other factors; such hyperactivity could be related to impairment of vascular resistance within the penis. Improvement of erectile function could be achieved after treatment for hypertension. There are many animal models to explain this theory. 16, 17 Pelvic atherosclerosis is another possible mechanism to explain this association. Decreasing in bladder blood flow can cause chronic ischemia, inducing collagen deposition and fibrosis, with loss of compliance, hyperactivity, as well as alteration of urethral resistence. 18 Even psychological effects due to LUTS have been associated with ED. 19 
Conclusion
Our findings in a prostate cancer screening population confirm that LUTS is an age-independent predictor of ED. Furthermore, they demonstrate that 
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